- The U.S. District Court for the Northern District of Ohio denies the Federal Trade Commission's request for a preliminary injunction to block Steris's (NYSE:STE) takeover of Synergy Health (OTC:SYHEF). The FTC sought to delay the deal until it could conduct an administrative trial on the merits of the transaction.
- Steris is now clear to consummate the merger, which CEO Walt Rosebrough says will be expeditious.
- STE shares are unchanged after hours.
- Previously: Steris to contest FTC action (May 29)
- Previously: FTC challenges Steris/Synergy Health merger on antitrust basis (May 29)